US Stock MarketDetailed Quotes

OPGN OpGen

Watchlist
  • 2.9521
  • -0.1319-4.28%
Close Jul 18 16:00 ET
  • 2.7119
  • -0.2402-8.14%
Post 17:47 ET
3.98MMarket Cap-102P/E (TTM)

About OpGen Company

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It engages in the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.

Company Profile

SymbolOPGN
Company NameOpGen
Listing DateMay 5, 2015
Issue Price6.00
Founded2001
CEOMr. David E. Lazar
MarketNASDAQ
Employees100
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address9717 Key West Avenue,Suite 100
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-301-869-9683

Company Executives

  • Name
  • Position
  • Salary
  • David E. Lazar
  • Chairman of the Board and Chief Executive Officer
  • --
  • Oliver Schacht, PhD
  • Executive Vice President of Corporate Development
  • 520.80K
  • David Natan
  • Independent Director
  • --
  • Matthew C. McMurdo, Esq.
  • Independent Director
  • --
  • Avraham Ben-Tzvi
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg